Inventor
WILSON KEVIN J
US31 patents
⚠️ This page may combine multiple inventors who share the name “WILSON KEVIN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BLUEPRINT MEDICINES CORP
18 patentsUS9944651B2Apr 17, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP33 citations98
US10584114B2Mar 10, 2020
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations94
US10030005B2Jul 24, 2018
Inhibitors of RET
BLUEPRINT MEDICINES CORP38 citations94
US10000496B2Jun 19, 2018
Compositions useful for treating disorders related to kit and PDGFR
BLUEPRINT MEDICINES CORP32 citations94
US9994575B2Jun 12, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP32 citations94
US10233186B2Mar 19, 2019
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP16 citations93
US10227329B2Mar 12, 2019
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP19 citations85
US11279688B2Mar 22, 2022
Inhibitors of RET
BLUEPRINT MEDICINES CORP5 citations84
US10807985B2Oct 20, 2020
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP7 citations84
US10183928B2Jan 22, 2019
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations84
US10669277B2Jun 2, 2020
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP9 citations77
US11827642B2Nov 28, 2023
Compositions useful for treating disorders related to KIT
BLUEPRINT MEDICINES CORP2 citations73
US11718602B2Aug 8, 2023
EGFR inhibitors
BLUEPRINT MEDICINES CORP2 citations70
US11634422B2Apr 25, 2023
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations70
US11040979B2Jun 22, 2021
Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
BLUEPRINT MEDICINES CORP0 citations62
US12595265B2Apr 7, 2026
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP0 citations59
US12172983B2Dec 24, 2024
EGFR inhibitors
BLUEPRINT MEDICINES CORP0 citations59
US12583856B2Mar 24, 2026
Inhibitors of protein kinase A
BLUEPRINT MEDICINES CORP0 citations43
MERCK SHARP & DOHME
7 patentsUS7834034B2Nov 16, 2010
Benzothiophene derivatives
MERCK SHARP & DOHME9 citations83
US7981874B2Jul 19, 2011
Phosphorus derivatives as histone deacetylase inhibitors
MERCK SHARP & DOHME21 citations82
US10759805B2Sep 1, 2020
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations51
US10065967B2Sep 4, 2018
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations51
US9745307B2Aug 29, 2017
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations51
US9233979B2Jan 12, 2016
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations38
US9226922B2Jan 5, 2016
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations38